{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T05:18:33Z","timestamp":1793337513908,"version":"4.5.0"},"reference-count":132,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T00:00:00Z","timestamp":1767312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T00:00:00Z","timestamp":1767312000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Cardiol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1038\/s41569-025-01233-z","type":"journal-article","created":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T02:10:50Z","timestamp":1767319850000},"page":"420-432","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Tricuspid valve disease: updates on diagnostic imaging and intervention"],"prefix":"10.1038","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4620-6234","authenticated-orcid":false,"given":"Julia","family":"Grapsa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Zancanaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl Philipp","family":"Rommel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augustin","family":"Coisne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Estevez-Loureiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1300-4732","authenticated-orcid":false,"given":"Marta","family":"Sitges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0910-5450","authenticated-orcid":false,"given":"Maurice","family":"Enriquez-Sarano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabien","family":"Praz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Fam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Cristell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azeem","family":"Latib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolo","family":"Piazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Lurz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Modine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Hausleiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1342-9191","authenticated-orcid":false,"given":"Rebecca T.","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin B.","family":"Leon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan F.","family":"Granada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,2]]},"reference":[{"key":"1233_CR1","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1161\/CIRCULATIONAHA.118.038946","volume":"140","author":"G Benfari","year":"2019","unstructured":"Benfari, G. et al. Excess mortality associated with functional tricuspid regurgitation complicating heart failure with reduced ejection fraction. Circulation 140, 196\u2013206 (2019).","journal-title":"Circulation"},{"key":"1233_CR2","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jcmg.2023.08.013","volume":"17","author":"J Grapsa","year":"2024","unstructured":"Grapsa, J. et al. Tricuspid regurgitation: from imaging to clinical trials to resolving the unmet need for treatment. J. Am. Coll. Cardiol. Img 17, 79\u201395 (2024).","journal-title":"J. Am. Coll. Cardiol. Img"},{"key":"1233_CR3","doi-asserted-by":"publisher","first-page":"4508","DOI":"10.1093\/eurheartj\/ehad653","volume":"44","author":"RT Hahn","year":"2023","unstructured":"Hahn, R. T. et al. Tricuspid Valve Academic Research Consortium definitions for tricuspid regurgitation and trial endpoints. Eur. Heart J. 44, 4508\u20134532 (2023).","journal-title":"Eur. Heart J."},{"key":"1233_CR4","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1093\/eurheartj\/ehad783","volume":"45","author":"M Andreas","year":"2024","unstructured":"Andreas, M. et al. Tricuspid valve disease and cardiac implantable electronic devices. Eur. Heart J. 45, 346\u2013365 (2024).","journal-title":"Eur. Heart J."},{"key":"1233_CR5","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1093\/eurheartj\/ehad585","volume":"45","author":"J Dreyfus","year":"2024","unstructured":"Dreyfus, J. et al. TRI-SCORE and benefit of intervention in patients with severe tricuspid regurgitation. Eur. Heart J. 45, 586\u2013597 (2024).","journal-title":"Eur. Heart J."},{"key":"1233_CR6","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.jtcvs.2011.07.004","volume":"143","author":"CM Vassileva","year":"2012","unstructured":"Vassileva, C. M. et al. Tricuspid valve surgery: the past 10 years from the nationwide inpatient sample (NIS) database. J. Thorac. Cardiovasc. Surg. 143, 1043\u20131049 (2012).","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"1233_CR7","doi-asserted-by":"publisher","first-page":"4512","DOI":"10.1093\/eurheartj\/ehae578","volume":"45","author":"J Dreyfus","year":"2024","unstructured":"Dreyfus, J. et al. Benefit of isolated surgical valve repair or replacement for functional tricuspid regurgitation and long-term outcomes stratified by the TRI-SCORE. Eur. Heart J. 45, 4512\u20134522 (2024).","journal-title":"Eur. Heart J."},{"key":"1233_CR8","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s11886-024-02051-4","volume":"26","author":"MV Madhavan","year":"2024","unstructured":"Madhavan, M. V. et al. Transcatheter therapy for the tricuspid valve: a focused review of edge-to-edge repair and orthotopic valve replacement. Curr. Cardiol. Rep. 26, 459\u2013474 (2024).","journal-title":"Curr. Cardiol. Rep."},{"key":"1233_CR9","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1056\/NEJMoa2115961","volume":"386","author":"JS Gammie","year":"2022","unstructured":"Gammie, J. S. et al. Concomitant tricuspid repair in patients with degenerative mitral regurgitation. N. Engl. J. Med. 386, 327\u2013339 (2022).","journal-title":"N. Engl. J. Med."},{"key":"1233_CR10","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0022-5223(19)39760-0","volume":"67","author":"A Carpentier","year":"1974","unstructured":"Carpentier, A. et al. Surgical management of acquired tricuspid valve disease. J. Thorac. Cardiovasc. Surg. 67, 53\u201365 (1974).","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"1233_CR11","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1016\/j.jacc.2016.02.065","volume":"67","author":"RA Nishimura","year":"2016","unstructured":"Nishimura, R. A. et al. Operationalizing the 2014 ACC\/AHA guidelines for valvular heart disease: a guide for clinicians. J. Am. Coll. Cardiol. 67, 2289\u20132294 (2016).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1233_CR12","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1093\/eurheartj\/ehae082","volume":"45","author":"F Maisano","year":"2024","unstructured":"Maisano, F. et al. Transcatheter treatment of the tricuspid valve: current status and perspectives. Eur. Heart J. 45, 876\u2013894 (2024).","journal-title":"Eur. Heart J."},{"key":"1233_CR13","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1016\/j.jacc.2023.03.392","volume":"81","author":"RT Hahn","year":"2023","unstructured":"Hahn, R. T. et al. Multimodality imaging of right heart function: JACC scientific statement. J. Am. Coll. Cardiol. 81, 1954\u20131973 (2023).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1233_CR14","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.jacc.2019.04.028","volume":"74","author":"AL Axtell","year":"2019","unstructured":"Axtell, A. L. et al. Surgery does not improve survival in patients with isolated severe tricuspid regurgitation. J. Am. Coll. Cardiol. 74, 715\u2013725 (2019).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1233_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s13019-024-03014-0","volume":"19","author":"M Abdul Qadeer","year":"2024","unstructured":"Abdul Qadeer, M. et al. Tricuspid valve replacement with mechanical versus biological prostheses: a systematic review and meta-analysis. J. Cardiothorac. Surg. 19, 636 (2024).","journal-title":"J. Cardiothorac. Surg."},{"key":"1233_CR16","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.1016\/j.jacc.2018.04.031","volume":"71","author":"L Asmarats","year":"2018","unstructured":"Asmarats, L. et al. Transcatheter tricuspid valve interventions: landscape, challenges, and future directions. J. Am. Coll. Cardiol. 71, 2935\u20132956 (2018).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1233_CR17","doi-asserted-by":"publisher","first-page":"791","DOI":"10.4244\/EIJ-D-21-00695","volume":"17","author":"F Praz","year":"2021","unstructured":"Praz, F. et al. Transcatheter treatment for tricuspid valve disease. EuroIntervention 17, 791\u2013808 (2021).","journal-title":"EuroIntervention"},{"key":"1233_CR18","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.119.006345","volume":"12","author":"M Pahuja","year":"2019","unstructured":"Pahuja, M. et al. Right ventricular afterload sensitivity has been on my mind. Circ. Heart Fail. 12, e006345 (2019).","journal-title":"Circ. Heart Fail."},{"key":"1233_CR19","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1016\/j.jcin.2019.02.042","volume":"12","author":"KP Rommel","year":"2019","unstructured":"Rommel, K. P. et al. Physiological and clinical consequences of right ventricular volume overload reduction after transcatheter treatment for tricuspid regurgitation. JACC Cardiovasc. Interv. 12, 1423\u20131434 (2019).","journal-title":"JACC Cardiovasc. Interv."},{"key":"1233_CR20","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jcin.2021.10.033","volume":"15","author":"Stolz L","year":"2022","unstructured":"Stolz L et al. Cardiohepatic syndrome is associated with poor prognosis in patients undergoing tricuspid transcatheter edge-to-edge valve repair. JACC Cardiovasc. Interv. 15, 179\u2013189 (2022).","journal-title":"JACC Cardiovasc. Interv."},{"key":"1233_CR21","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1093\/eurheartj\/ehae733","volume":"46","author":"P Lurz","year":"2025","unstructured":"Lurz, P., Zancanaro, E. & Kresoja, K.-P Personalized management of tricuspid valve regurgitation. Eur. Heart J. 46, 882\u2013884 (2025).","journal-title":"Eur. Heart J."},{"key":"1233_CR22","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1161\/CIRCHEARTFAILURE.114.001575","volume":"7","author":"MJ Andersen","year":"2014","unstructured":"Andersen, M. J. et al. The hemodynamic basis of exercise intolerance in tricuspid regurgitation. Circ. Heart Fail. 7, 911\u2013917 (2014).","journal-title":"Circ. Heart Fail."},{"key":"1233_CR23","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jcin.2020.09.033","volume":"14","author":"TJ Stocker","year":"2021","unstructured":"Stocker, T. J. et al. Cardiopulmonary hemodynamic profile predicts mortality after transcatheter tricuspid valve repair in chronic heart failure. JACC Cardiovasc. Interv. 14, 29\u201338 (2021).","journal-title":"JACC Cardiovasc. Interv."},{"key":"1233_CR24","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1136\/hrt.2008.155523","volume":"95","author":"WA Jaber","year":"2009","unstructured":"Jaber, W. A. et al. Differentiation of tricuspid regurgitation from constrictive pericarditis: novel criteria for diagnosis in the cardiac catheterisation laboratory. Heart 95, 1449\u20131454 (2009).","journal-title":"Heart"},{"key":"1233_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13206144","volume":"13","author":"F Cannata","year":"2023","unstructured":"Cannata, F. et al. Key imaging factors for transcatheter management of tricuspid regurgitation: device and patient selection. J. Clin. Med. 13, 6144 (2023).","journal-title":"J. Clin. Med."},{"key":"1233_CR26","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1016\/j.jcin.2021.05.005","volume":"14","author":"KP Kresoja","year":"2021","unstructured":"Kresoja, K. P. et al. Right ventricular contraction patterns in patients undergoing transcatheter tricuspid valve repair for severe tricuspid regurgitation. JACC Cardiovasc. Interv. 14, 1551\u20131561 (2021).","journal-title":"JACC Cardiovasc. Interv."},{"key":"1233_CR27","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1016\/j.echo.2023.06.014","volume":"36","author":"M Gavazzoni","year":"2023","unstructured":"Gavazzoni, M. et al. Clinical value of a novel three-dimensional echocardiography-derived index of right ventricle-pulmonary artery coupling in tricuspid regurgitation. J. Am. Soc. Echocardiogr. 36, 1154\u20131166 (2023).","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"1233_CR28","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1093\/ehjci\/jead070","volume":"24","author":"CJ Kane","year":"2023","unstructured":"Kane, C. J. et al. Pulmonary artery pulsatility index in patients with tricuspid valve regurgitation: a simple non-invasive tool for risk stratification. Eur. Heart J. Cardiovasc. Imaging 24, 1210\u20131221 (2023).","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"1233_CR29","doi-asserted-by":"publisher","first-page":"852","DOI":"10.4244\/EIJ-D-22-00045","volume":"18","author":"A Sugiura","year":"2022","unstructured":"Sugiura, A. et al. Impact of right ventricular-pulmonary arterial coupling on clinical outcomes of tricuspid regurgitation. EuroIntervention 18, 852\u2013861 (2022).","journal-title":"EuroIntervention"},{"key":"1233_CR30","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1002\/ejhf.3195","volume":"26","author":"KP Kresoja","year":"2024","unstructured":"Kresoja, K. P. et al. Implications of tricuspid regurgitation and right ventricular volume overload in patients with heart failure with preserved ejection fraction. Eur. J. Heart Fail. 26, 1025\u20131035 (2024).","journal-title":"Eur. J. Heart Fail."},{"key":"1233_CR31","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1016\/j.jcin.2023.05.010","volume":"16","author":"KP Rommel","year":"2023","unstructured":"Rommel, K. P. et al. Low-cardiac output syndrome after tricuspid valve repair: insights from the TriValve Registry. JACC Cardiovasc. Interv. 16, 1703\u20131705 (2023).","journal-title":"JACC Cardiovasc. Interv."},{"key":"1233_CR32","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.jcmg.2022.10.004","volume":"16","author":"L Stolz","year":"2023","unstructured":"Stolz, L. et al. EuroTR investigators. Invasive right ventricular to pulmonary artery coupling in patients undergoing transcatheter edge-to-edge tricuspid valve repair. JACC Cardiovasc. Imaging 16, 564\u2013566 (2023).","journal-title":"JACC Cardiovasc. Imaging"},{"key":"1233_CR33","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.jacc.2024.10.071","volume":"85","author":"J Hausleiter","year":"2025","unstructured":"Hausleiter, J. et al. Transcatheter tricuspid valve replacement. J. Am. Coll. Cardiol. 85, 265\u2013291 (2025).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1233_CR34","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.121.009101","volume":"15","author":"MI Brener","year":"2022","unstructured":"Brener, M. I. et al. Invasive right ventricular pressure-volume analysis: basic principles, clinical applications, and practical recommendations. Circ. Heart Fail. 15, e009101 (2022).","journal-title":"Circ. Heart Fail."},{"key":"1233_CR35","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1093\/eurheartj\/ehaa138","volume":"41","author":"P Lurz","year":"2020","unstructured":"Lurz, P. et al. Clinical characteristics, diagnosis, and risk stratification of pulmonary hypertension in severe tricuspid regurgitation and implications for transcatheter tricuspid valve repair. Eur. Heart J. 41, 2785\u20132795 (2020).","journal-title":"Eur. Heart J."},{"key":"1233_CR36","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.jcin.2021.12.043","volume":"15","author":"V Fortmeier","year":"2022","unstructured":"Fortmeier, V. et al. Solving the pulmonary hypertension paradox in patients with severe tricuspid regurgitation by employing artificial intelligence. JACC Cardiovasc. Interv. 15, 381\u2013394 (2022).","journal-title":"JACC Cardiovasc. Interv."},{"key":"1233_CR37","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/j.jcin.2024.02.020","volume":"17","author":"T Tanaka","year":"2024","unstructured":"Tanaka, T. et al. Pulmonary artery pulsatility index and clinical outcomes in patients undergoing transcatheter tricuspid valve interventions. JACC Cardiovasc. Interv. 17, 952\u2013954 (2024).","journal-title":"JACC Cardiovasc. Interv."},{"key":"1233_CR38","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1002\/ejhf.3235","volume":"26","author":"KP Rommel","year":"2024","unstructured":"Rommel, K. P. et al. Congestion patterns in severe tricuspid regurgitation and transcatheter treatment: insights from a multicentre registry. Eur. J. Heart Fail. 26, 1004\u20131014 (2024).","journal-title":"Eur. J. Heart Fail."},{"key":"1233_CR39","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1016\/j.jcin.2023.07.040","volume":"16","author":"KP Rommel","year":"2023","unstructured":"Rommel, K. P. et al. Stressed blood volume in severe tricuspid regurgitation: implications for transcatheter treatment. JACC Cardiovasc. Interv. 16, 2245\u20132258 (2023).","journal-title":"JACC Cardiovasc. Interv."},{"key":"1233_CR40","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1016\/S0140-6736(19)32600-5","volume":"394","author":"G Nickenig","year":"2019","unstructured":"Nickenig, G. et al. Transcatheter edge-to-edge repair for reduction of tricuspid regurgitation: 6-month outcomes of the TRILUMINATE single-arm study. Lancet 394, 2002\u20132011 (2019).","journal-title":"Lancet"},{"key":"1233_CR41","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.jacc.2020.11.038","volume":"77","author":"P Lurz","year":"2021","unstructured":"Lurz, P. et al. TRILUMINATE investigators. Transcatheter edge-to-edge repair for treatment of tricuspid regurgitation. J. Am. Coll. Cardiol. 77, 229\u2013239 (2021).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1233_CR42","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.125.074536","author":"S Kar","year":"2025","unstructured":"Kar, S. et al. Two-year outcomes of transcatheter edge-to-edge repair for severe tricuspid regurgitation: the TRILUMINATE Pivotal randomized trial. Circulation https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.125.074536 (2025).","journal-title":"Circulation"},{"key":"1233_CR43","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1093\/eurheartj\/ehae088","volume":"45","author":"D Muraru","year":"2024","unstructured":"Muraru, D. et al. Atrial secondary tricuspid regurgitation: pathophysiology, definition, diagnosis, and treatment. Eur. Heart J. 45, 895\u2013911 (2024).","journal-title":"Eur. Heart J."},{"key":"1233_CR44","doi-asserted-by":"publisher","DOI":"10.1093\/ehjimp\/qyae017","volume":"2","author":"M Mazzola","year":"2024","unstructured":"Mazzola, M. et al. Transthoracic and transoesophageal echocardiography for tricuspid transcatheter edge-to-edge repair: a step-by-step protocol. Eur. Heart J. Imaging Methods Pract. 2, qyae017 (2024).","journal-title":"Eur. Heart J. Imaging Methods Pract."},{"key":"1233_CR45","doi-asserted-by":"publisher","first-page":"e171","DOI":"10.1093\/ehjci\/jeab253","volume":"23","author":"P Lancellotti","year":"2022","unstructured":"Lancellotti, P. et al. Multi-modality imaging assessment of native valvular regurgitation: an EACVI and ESC council of valvular heart disease position paper. Eur. Heart J. Cardiovasc. Imaging 23, e171\u2013e232 (2022).","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"1233_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.echo.2021.07.006","volume":"35","author":"RT Hahn","year":"2022","unstructured":"Hahn, R. T. et al. Recommended standards for the performance of transesophageal echocardiographic screening for structural heart intervention: from the American Society of Echocardiography. J. Am. Soc. Echocardiogr. 35, 1\u201376 (2022).","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"1233_CR47","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1093\/ejechocard\/jep169","volume":"11","author":"J Grapsa","year":"2010","unstructured":"Grapsa, J. et al. Right ventricular remodelling in pulmonary arterial hypertension with three-dimensional echocardiography: comparison with cardiac magnetic resonance imaging. Eur. J. Echocardiogr. 11, 64\u201373 (2010).","journal-title":"Eur. J. Echocardiogr."},{"key":"1233_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2023.1171968","volume":"10","author":"S Tomlinson","year":"2023","unstructured":"Tomlinson, S. et al. Multimodality imaging for transcatheter tricuspid valve repair and replacement. Front. Cardiovasc. Med. 10, 1171968 (2023).","journal-title":"Front. Cardiovasc. Med."},{"key":"1233_CR49","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/j.echo.2013.07.020","volume":"26","author":"TE Chen","year":"2013","unstructured":"Chen, T. E. et al. Three-dimensional color doppler echocardiographic quantification of tricuspid regurgitation orifice area: comparison with conventional two-dimensional measures. J. Am. Soc. Echocardiogr. 26, 1143\u20131152 (2013).","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"1233_CR50","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.jcmg.2018.11.015","volume":"12","author":"A Dahou","year":"2019","unstructured":"Dahou, A. et al. Quantifying tricuspid regurgitation severity: a comparison of proximal isovelocity surface area and novel quantitative Doppler methods. JACC Cardiovasc. Imaging 12, 560\u2013562 (2019).","journal-title":"JACC Cardiovasc. Imaging"},{"key":"1233_CR51","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1016\/j.echo.2019.07.022","volume":"32","author":"H Utsunomiya","year":"2019","unstructured":"Utsunomiya, H. et al. Comprehensive evaluation of tricuspid regurgitation location and severity using vena contracta analysis: a color Doppler three-dimensional transesophageal echocardiographic study. J. Am. Soc. Echocardiogr. 32, 1526\u20131537.e2 (2019).","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"1233_CR52","doi-asserted-by":"publisher","first-page":"e94","DOI":"10.1093\/ehjci\/jeab040","volume":"23","author":"RT Hahn","year":"2022","unstructured":"Hahn, R. T. et al. State-of-the-art intra-procedural imaging for the mitral and tricuspid PASCAL repair system. Eur. Heart J. Cardiovasc. Imaging 23, e94\u2013e110 (2022).","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"1233_CR53","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1016\/j.jcin.2024.07.034","volume":"17","author":"RT Hahn","year":"2024","unstructured":"Hahn, R. T. et al. EVOQUE tricuspid valve replacement system: state-of-the-art screening and intraprocedural guidance. JACC Cardiovasc. Interv. 17, 2093\u20132112 (2024).","journal-title":"JACC Cardiovasc. Interv."},{"key":"1233_CR54","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jcmg.2024.05.012","volume":"18","author":"GHL Tang","year":"2025","unstructured":"Tang, G. H. L. et al. Structural heart imaging using 3-dimensional intracardiac echocardiography: JACC cardiovascular imaging position statement. JACC Cardiovasc. Imaging 18, 93\u2013115 (2025).","journal-title":"JACC Cardiovasc. Imaging"},{"key":"1233_CR55","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.jcmg.2017.08.022","volume":"12","author":"K Addetia","year":"2019","unstructured":"Addetia, K. et al. 3-Dimensional echocardiographic analysis of the tricuspid annulus provides new insights into tricuspid valve geometry and dynamics. JACC Cardiovascular Imaging 12, 401\u2013412 (2019).","journal-title":"JACC Cardiovascular Imaging"},{"key":"1233_CR56","doi-asserted-by":"publisher","DOI":"10.1186\/s12968-020-00683-3","volume":"22","author":"N Kawel-Boehm","year":"2020","unstructured":"Kawel-Boehm, N. et al. Reference ranges (\u201cnormal values\u201d) for cardiovascular magnetic resonance (CMR) in adults and children: 2020 update. J. Cardiovasc. Magn. Reson. 22, 87 (2020).","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"1233_CR57","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1148\/radiol.2016151556","volume":"280","author":"JB Park","year":"2016","unstructured":"Park, J. B. et al. Prognostic value of cardiac MR imaging for preoperative assessment of patients with severe functional tricuspid regurgitation. Radiology 280, 723\u2013734 (2016).","journal-title":"Radiology"},{"key":"1233_CR58","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.echo.2017.01.007","volume":"30","author":"WA Zoghbi","year":"2017","unstructured":"Zoghbi, W. A. et al. Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the American Society of Echocardiography developed in collaboration with the Society for Cardiovascular Magnetic Resonance. J. Am. Soc. Echocardiogr. 30, 303\u2013371 (2017).","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"1233_CR59","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13154481","volume":"13","author":"LL Pype","year":"2024","unstructured":"Pype, L. L. et al. Assessment of tricuspid regurgitation by cardiac magnetic resonance imaging: current role and future applications. J. Clin. Med. 13, 4481 (2024).","journal-title":"J. Clin. Med."},{"key":"1233_CR60","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1016\/j.jacc.2020.07.036","volume":"76","author":"Y Zhan","year":"2020","unstructured":"Zhan, Y. et al. Natural history of functional tricuspid regurgitation quantified by cardiovascular magnetic resonance. J. Am. Coll. Cardiol. 76, 1291\u20131301 (2020).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1233_CR61","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1002\/jmri.26040","volume":"48","author":"JF Feneis","year":"2018","unstructured":"Feneis, J. F. et al. 4D flow MRI quantification of mitral and tricuspid regurgitation: reproducibility and consistency relative to conventional MRI. J. Magn. Reson. Imaging 48, 1147\u20131158 (2018).","journal-title":"J. Magn. Reson. Imaging"},{"key":"1233_CR62","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.jcmg.2019.01.041","volume":"13","author":"TC Pulerwitz","year":"2020","unstructured":"Pulerwitz, T. C. et al. Optimizing cardiac CT protocols for comprehensive acquisition prior to percutaneous MV and TV repair\/replacement. JACC Cardiovasc. Imaging 13, 836\u2013850 (2020).","journal-title":"JACC Cardiovasc. Imaging"},{"key":"1233_CR63","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1093\/ehjci\/jeaa308","volume":"22","author":"MM Hell","year":"2021","unstructured":"Hell, M. M. et al. Computed tomography imaging needs for novel transcatheter tricuspid valve repair and replacement therapies. Eur. Heart J. Cardiovasc. Imaging 22, 601\u2013610 (2021).","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"1233_CR64","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1016\/j.jcmg.2021.02.002","volume":"14","author":"BBC Lopes","year":"2021","unstructured":"Lopes, B. B. C. et al. Tricuspid anatomic regurgitant orifice area by functional DSCT: a novel parameter of tricuspid regurgitation severity. JACC Cardiovasc. Imaging 14, 1669\u20131672 (2021).","journal-title":"JACC Cardiovasc. Imaging"},{"key":"1233_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-70768-x","volume":"14","author":"I Mattig","year":"2024","unstructured":"Mattig, I. et al. Predictors of residual tricuspid regurgitation after interventional therapy: an automated deep-learning CT analysis. Sci. Rep. 14, 19946 (2024).","journal-title":"Sci. Rep."},{"key":"1233_CR66","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.jcct.2024.02.001","volume":"18","author":"J Bartkowiak","year":"2024","unstructured":"Bartkowiak, J. et al. Computed tomography anatomic predictors of outcomes in patients undergoing tricuspid transcatheter edge-to-edge repair. J. Cardiovasc. Comput. Tomogr. 18, 259\u2013266 (2024).","journal-title":"J. Cardiovasc. Comput. Tomogr."},{"key":"1233_CR67","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1136\/heartjnl-2022-322236","volume":"109","author":"RT Hahn","year":"2023","unstructured":"Hahn, R. T. Understanding the anatomy of the mitral valve: attitudinal is unnecessary. Heart 109, 728\u2013729 (2023).","journal-title":"Heart"},{"key":"1233_CR68","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.echo.2016.01.013","volume":"29","author":"JJ Thaden","year":"2016","unstructured":"Thaden, J. J. et al. Echocardiographic and fluoroscopic fusion imaging for procedural guidance: an overview and early clinical experience. J. Am. Soc. Echocardiogr. 29, 503\u2013512 (2016).","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"1233_CR69","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1093\/ehjci\/jey062","volume":"19","author":"A Pozzoli","year":"2018","unstructured":"Pozzoli, A. et al. 3D echo-fluoro fusion imaging to guide Cardioband transcatheter mitral annuloplasty. Eur. Heart J. Cardiovasc. Imaging 19, 827 (2018).","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"1233_CR70","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1016\/j.jchf.2024.08.020","volume":"12","author":"W Doehner","year":"2022","unstructured":"Doehner, W. et al. Uric acid and SGLT2 inhibition with empagliflozin in heart failure with preserved ejection fraction: the EMPEROR-Preserved trial. JACC Heart Fail. 12, 2057\u20132070 (2022).","journal-title":"JACC Heart Fail."},{"key":"1233_CR71","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1002\/ejhf.2858","volume":"25","author":"G Heitzinger","year":"2023","unstructured":"Heitzinger, G. et al. Contemporary insights into the epidemiology, impact and treatment of secondary tricuspid regurgitation across the heart failure spectrum. Eur. J. Heart Fail. 25, 857\u2013867 (2023).","journal-title":"Eur. J. Heart Fail."},{"key":"1233_CR72","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1016\/S0140-6736(22)02076-1","volume":"400","author":"A Mebazaa","year":"2022","unstructured":"Mebazaa, A. et al. Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial. Lancet 400, 1938\u20131952 (2022).","journal-title":"Lancet"},{"key":"1233_CR73","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT06667128."},{"key":"1233_CR74","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1136\/heartjnl-2023-323244","volume":"110","author":"MJ Cha","year":"2024","unstructured":"Cha, M. J. et al. Reduction of moderate to severe tricuspid regurgitation after catheter ablation for atrial fibrillation. Heart 110, 523\u2013530 (2024).","journal-title":"Heart"},{"key":"1233_CR75","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.jacc.2021.12.029","volume":"79","author":"L Soulat-Dufour","year":"2022","unstructured":"Soulat-Dufour, L. et al. Restoring sinus rhythm reverses cardiac remodeling and reduces valvular regurgitation in patients with atrial fibrillation. J. Am. Coll. Cardiol. 79, 951\u2013961 (2022).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1233_CR76","doi-asserted-by":"publisher","DOI":"10.1186\/s13019-024-02891-9","volume":"19","author":"Y Zhan","year":"2024","unstructured":"Zhan, Y. et al. Sinus rhythm restoration reverses tricuspid regurgitation in patients with atrial fibrillation: a systematic review and meta-analysis. J. Cardiothorac. Surg. 19, 411 (2024).","journal-title":"J. Cardiothorac. Surg."},{"key":"1233_CR77","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1007\/s10554-020-01824-6","volume":"36","author":"J Mukai","year":"2020","unstructured":"Mukai, J. et al. Associations between functional tricuspid regurgitation and long-term outcomes for patients with pulmonary hypertension. Int. J. Cardiovasc. Imaging 36, 1261\u20131269 (2020).","journal-title":"Int. J. Cardiovasc. Imaging"},{"key":"1233_CR78","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1093\/ejcts\/ezab111","volume":"60","author":"D Carino","year":"2021","unstructured":"Carino, D. et al. Long-term results of tricuspid annuloplasty with 3-dimensional-shaped rings: effective and durable!. Eur. J. Cardiothorac. Surg. 60, 115\u2013121 (2021).","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"1233_CR79","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1067\/mtc.2001.117277","volume":"122","author":"O Alfieri","year":"2001","unstructured":"Alfieri, O. et al. The double-orifice technique in mitral valve repair: a simple solution for complex problems. J. Thorac. Cardiovasc. Surg. 122, 674\u2013681 (2001).","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"1233_CR80","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.jcmg.2024.04.008","volume":"17","author":"M Ger\u00e7ek","year":"2024","unstructured":"Ger\u00e7ek, M. et al. GLIDE Score: scoring system for prediction of procedural success in tricuspid valve transcatheter edge-to-edge repair. JACC Cardiovasc. Imaging 17, 729\u2013742 (2024).","journal-title":"JACC Cardiovasc. Imaging"},{"key":"1233_CR81","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaf194","author":"F Praz","year":"2025","unstructured":"Praz, F. et al. 2025 ESC\/EACTS guidelines for the management of valvular heart disease. Eur. Heart J. https:\/\/doi.org\/10.1093\/eurheartj\/ehaf194 (2025).","journal-title":"Eur. Heart J."},{"key":"1233_CR82","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1016\/j.jcin.2024.08.035","volume":"17","author":"DH Adams","year":"2024","unstructured":"Adams, D. H. et al. Transcatheter edge-to-edge repair in patients with complex tricuspid valve anatomy. JACC Cardiovasc. Interv. 17, 2749\u20132760 (2024).","journal-title":"JACC Cardiovasc. Interv."},{"key":"1233_CR83","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1016\/j.jcin.2024.05.036","volume":"17","author":"G Nickenig","year":"2024","unstructured":"Nickenig, G. et al. Percutaneous edge-to-edge repair for tricuspid regurgitation: 3-year outcomes from the TRILUMINATE study. JACC Cardiovasc. Interv. 17, 2113\u20132122 (2024).","journal-title":"JACC Cardiovasc. Interv."},{"key":"1233_CR84","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1001\/jama.2024.21189","volume":"333","author":"E Donal","year":"2025","unstructured":"Donal, E. et al. Transcatheter edge-to-edge repair for severe isolated tricuspid regurgitation: the Tri.Fr randomized clinical trial. JAMA 333, 124\u2013132 (2025).","journal-title":"JAMA"},{"key":"1233_CR85","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.jacc.2024.05.006","volume":"84","author":"P Lurz","year":"2024","unstructured":"Lurz, P. et al. Real-world 1-year results of tricuspid edge-to-edge repair from the bRIGHT study. J. Am. Coll. Cardiol. 84, 607\u2013616 (2024).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1233_CR86","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1016\/j.jacc.2023.02.049","volume":"81","author":"SK Kodali","year":"2023","unstructured":"Kodali, S. K. et al. 1-Year outcomes of transcatheter tricuspid valve repair. J. Am. Coll. Cardiol. 81, 1766\u20131776 (2023).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1233_CR87","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1016\/j.jcin.2022.05.041","volume":"15","author":"MG Wild","year":"2022","unstructured":"Wild, M. G. et al. Multicenter experience with the transcatheter leaflet repair system for symptomatic tricuspid regurgitation. JACC Cardiovasc. Interv. 15, 1352\u20131363 (2022).","journal-title":"JACC Cardiovasc. Interv."},{"key":"1233_CR88","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT04097145."},{"key":"1233_CR89","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.jcin.2024.10.058","volume":"18","author":"G Giustino","year":"2025","unstructured":"Giustino, G. et al. Early outcomes of transjugular transcatheter tricuspid valve replacement. JACC Cardiovasc. Interv. 18, 542\u2013544 (2025).","journal-title":"JACC Cardiovasc. Interv."},{"key":"1233_CR90","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.jcin.2022.01.280","volume":"15","author":"JG Webb","year":"2022","unstructured":"Webb, J. G. et al. Transcatheter tricuspid valve replacement with the EVOQUE System: 1-year outcomes of a multicenter, first-in-human experience. JACC Cardiovasc. Interv. 15, 481\u2013491 (2022).","journal-title":"JACC Cardiovasc. Interv."},{"key":"1233_CR91","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.1016\/j.jcin.2024.09.064","volume":"17","author":"NP Fam","year":"2024","unstructured":"Fam, N. P. et al. EVOQUE transcatheter tricuspid valve replacement: 5 years on. JACC Cardiovasc. Interv. 17, 2829\u20132830 (2024).","journal-title":"JACC Cardiovasc. Interv."},{"key":"1233_CR92","doi-asserted-by":"publisher","first-page":"4862","DOI":"10.1093\/eurheartj\/ehad667","volume":"44","author":"S Kodali","year":"2023","unstructured":"Kodali, S. et al. Transfemoral tricuspid valve replacement and one-year outcomes: the TRISCEND study. Eur. Heart J. 44, 4862\u20134873 (2023).","journal-title":"Eur. Heart J."},{"key":"1233_CR93","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.jacc.2024.10.067","volume":"85","author":"SV Arnold","year":"2025","unstructured":"Arnold, S. V. et al. Quality of life after transcatheter tricuspid valve replacement: 1-year results from TRISCEND II pivotal trial. J. Am. Coll. Cardiol. 85, 206\u2013216 (2025).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1233_CR94","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.amjcard.2024.06.009","volume":"225","author":"PA Grayburn","year":"2024","unstructured":"Grayburn, P. A. et al. TRISCEND II: novel randomized trial design for transcatheter tricuspid valve replacement. Am. J. Cardiol. 225, 171\u2013177 (2024).","journal-title":"Am. J. Cardiol."},{"key":"1233_CR95","doi-asserted-by":"publisher","first-page":"e1088","DOI":"10.4244\/EIJ-D-22-00517","volume":"8","author":"Y Zhang","year":"2023","unstructured":"Zhang, Y. et al. A first-in-human study of transjugular transcatheter tricuspid valve replacement with the LuX-valve plus system. EuroIntervention 8, e1088\u2013e1089 (2023).","journal-title":"EuroIntervention"},{"key":"1233_CR96","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.jcin.2023.12.023","volume":"17","author":"NP Fam","year":"2024","unstructured":"Fam, N. P. et al. Transcatheter tricuspid valve replacement with the Cardiovalve system. JACC Cardiovasc. Interv. 17, 586\u2013588 (2024).","journal-title":"JACC Cardiovasc. Interv."},{"key":"1233_CR97","doi-asserted-by":"publisher","first-page":"662","DOI":"10.4244\/EIJ-D-23-00079","volume":"19","author":"P Sorajja","year":"2023","unstructured":"Sorajja, P. et al. First-in-human description of a novel transcatheter tricuspid valve prosthesis to preserve the asymmetric shape of the right ventricle. EuroIntervention 19, 662\u2013663 (2023).","journal-title":"EuroIntervention"},{"key":"1233_CR98","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaccas.2023.101841","volume":"14","author":"L Sondergaard","year":"2023","unstructured":"Sondergaard, L. et al. First-in-human implantation of a new transcatheter tricuspid valve replacement system. JACC Case Rep. 14, 101841 (2023).","journal-title":"JACC Case Rep."},{"key":"1233_CR99","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT05194423."},{"key":"1233_CR100","doi-asserted-by":"publisher","DOI":"10.15420\/usc.2023.07","volume":"17","author":"MA Shabbir","year":"2023","unstructured":"Shabbir, M. A. et al. Transcatheter tricuspid valve replacement: case selection, technical considerations, and procedural planning. US Cardiol. Rev. 17, e11 (2023).","journal-title":"US Cardiol. Rev."},{"key":"1233_CR101","doi-asserted-by":"publisher","first-page":"862","DOI":"10.4244\/EIJ-D-22-00277","volume":"18","author":"E Teiger","year":"2022","unstructured":"Teiger, E. et al. First-in-human implantation of the Topaz transcatheter tricuspid valve replacement system. EuroIntervention 18, 862\u2013864 (2022).","journal-title":"EuroIntervention"},{"key":"1233_CR102","first-page":"95","volume":"11","author":"A Lauten","year":"2022","unstructured":"Lauten, A. et al. Caval valve implantation. Interv. Cardiol. Clin. 11, 95\u2013102 (2022).","journal-title":"Interv. Cardiol. Clin."},{"key":"1233_CR103","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.jacc.2019.05.019","volume":"74","author":"M Laule","year":"2019","unstructured":"Laule, M. et al. Inferior caval valve implantation versus optimal medical therapy for severe tricuspid regurgitation. J. Am. Coll. Cardiol. 74, 473\u2013475 (2019).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1233_CR104","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1016\/j.jcin.2022.05.022","volume":"15","author":"R Est\u00e9vez-Loureiro","year":"2022","unstructured":"Est\u00e9vez-Loureiro, R. et al. 6-Month outcomes of the TricValve system in patients with tricuspid regurgitation: the TRICUS EURO study. JACC Cardiovasc. Interv. 15, 1366\u20131377 (2022).","journal-title":"JACC Cardiovasc. Interv."},{"key":"1233_CR105","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.121.011302","volume":"15","author":"MG Wild","year":"2022","unstructured":"Wild, M. G. et al. Early clinical experience with the TRICENTO bicaval valved stent for treatment of symptomatic severe tricuspid regurgitation: a multicenter registry. Circ. Cardiovasc. Interv. 15, e011302 (2022).","journal-title":"Circ. Cardiovasc. Interv."},{"key":"1233_CR106","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.4244\/EIJ-D-19-00901","volume":"15","author":"H Dreger","year":"2020","unstructured":"Dreger, H. et al. Treatment of severe tricuspid regurgitation in patients with advanced heart failure with caval vein implantation of the Edwards Sapien XT valve (TRICAVAL): a randomised controlled trial. EuroIntervention 15, 1506\u20131513 (2020).","journal-title":"EuroIntervention"},{"key":"1233_CR107","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10194601","volume":"10","author":"O Abdul-Jawad Altisent","year":"2021","unstructured":"Abdul-Jawad Altisent, O. et al. Caval valve implantation (CAVI): an emerging therapy for treating severe tricuspid regurgitation. J. Clin. Med. 10, 4601 (2021).","journal-title":"J. Clin. Med."},{"key":"1233_CR108","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jcin.2023.10.043","volume":"17","author":"S Blasco-Turri\u00f3n","year":"2024","unstructured":"Blasco-Turri\u00f3n, S. et al. Bicaval TricValve implantation in patients with severe symptomatic tricuspid regurgitation: 1-year follow-up outcomes. JACC Cardiovasc. Interv. 17, 60\u201372 (2024).","journal-title":"JACC Cardiovasc. Interv."},{"key":"1233_CR109","doi-asserted-by":"publisher","first-page":"E450","DOI":"10.4244\/EIJ-D-23-00077","volume":"19","author":"IJ Amat-Santos","year":"2023","unstructured":"Amat-Santos, I. J. et al. Right heart remodelling after bicaval TricValve implantation in patients with severe tricuspid regurgitation. EuroIntervention 19, E450\u2013E452 (2023).","journal-title":"EuroIntervention"},{"key":"1233_CR110","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaccas.2022.08.025","volume":"6","author":"P Cust\u00f3dio","year":"2022","unstructured":"Cust\u00f3dio, P. et al. Bicaval transcatheter prosthesis implantation for treatment of tricuspid regurgitation: first report of thrombosis. JACC Case Rep. 6, 101609 (2022).","journal-title":"JACC Case Rep."},{"key":"1233_CR111","doi-asserted-by":"publisher","DOI":"10.1093\/ehjcr\/ytad368","volume":"7","author":"A Grazina","year":"2023","unstructured":"Grazina, A. et al. Heterotopic caval valve-in-valve procedure for prosthetic migration: two case reports. Eur. Heart J. Case Rep. 7, ytad368 (2023).","journal-title":"Eur. Heart J. Case Rep."},{"key":"1233_CR112","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.recesp.2022.12.007","volume":"76","author":"I Cruz-Gonz\u00e1lez","year":"2023","unstructured":"Cruz-Gonz\u00e1lez, I. et al. Trillium: a new treatment for severe tricuspid regurgitation. Rev. Esp. Cardiol. (Engl. Ed.) 76, 750 (2023).","journal-title":"Rev. Esp. Cardiol. (Engl. Ed.)"},{"key":"1233_CR113","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1016\/j.jcin.2025.04.036","volume":"18","author":"P Lurz","year":"2025","unstructured":"Lurz, P. et al. Heterotopic crosscaval transcatheter tricuspid valve replacement for patients with tricuspid regurgitation: the trillium device. JACC Cardiovasc. Interv. 18, 1425\u20131434 (2025).","journal-title":"JACC Cardiovasc. Interv."},{"key":"1233_CR114","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaccas.2023.102103","volume":"28","author":"A Sisinni","year":"2023","unstructured":"Sisinni, A. et al. First-in-human treatment of severe tricuspid regurgitation using a novel cross-caval heterotopic device. JACC Case Rep. 28, 102103 (2023).","journal-title":"JACC Case Rep."},{"key":"1233_CR115","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2024.1447411","volume":"11","author":"F Rudolph","year":"2024","unstructured":"Rudolph, F. et al. Time to assess more than prognosis: advancements and challenges in transcatheter tricuspid valve interventions. Front. Cardiovasc. Med. 11, 1447411 (2024).","journal-title":"Front. Cardiovasc. Med."},{"key":"1233_CR116","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1016\/j.jcin.2024.08.009","volume":"17","author":"G Russo","year":"2024","unstructured":"Russo, G. et al. TRIVALVE score: a risk score for mortality\/hospitalization prediction in patients undergoing transcatheter tricuspid valve intervention. JACC Cardiovasc. Interv. 17, 2170\u20132179 (2024).","journal-title":"JACC Cardiovasc. Interv."},{"key":"1233_CR117","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1016\/j.jcin.2024.04.013","volume":"17","author":"J von Stein","year":"2024","unstructured":"von Stein, J. et al. Performance of transcatheter direct annuloplasty in patients with atrial and nonatrial functional tricuspid regurgitation. JACC Cardiovasc. Interv. 17, 1470\u20131481 (2024).","journal-title":"JACC Cardiovasc. Interv."},{"key":"1233_CR118","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1016\/j.jcin.2022.07.006","volume":"15","author":"WA Gray","year":"2022","unstructured":"Gray, W. A. et al. Cardioband TR EFS investigators. 1-year outcomes of cardioband tricuspid valve reconstruction system early feasibility study. JACC Cardiovasc. Interv. 15, 1921\u20131932 (2022).","journal-title":"JACC Cardiovasc. Interv."},{"key":"1233_CR119","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jcin.2020.10.017","volume":"14","author":"CJ Davidson","year":"2021","unstructured":"Davidson, C. J. et al. Early feasibility study of cardioband tricuspid system for functional tricuspid regurgitation: 30-day outcomes. JACC Cardiovasc. Interv. 14, 41\u201350 (2021).","journal-title":"JACC Cardiovasc. Interv."},{"key":"1233_CR120","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.120.010019","volume":"14","author":"MI K\u00f6rber","year":"2021","unstructured":"K\u00f6rber, M. I. et al. Transcatheter treatment of secondary tricuspid regurgitation with direct annuloplasty: results from a multicenter real-world experience. Circ. Cardiovasc. Interv. 14, e010019 (2021).","journal-title":"Circ. Cardiovasc. Interv."},{"key":"1233_CR121","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1016\/j.jacc.2019.01.062","volume":"73","author":"G Nickenig","year":"2019","unstructured":"Nickenig, G. et al. 6-Month outcomes of tricuspid valve reconstruction for patients with severe tricuspid regurgitation. J. Am. Coll. Cardiol. 73, 1905\u20131915 (2019).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1233_CR122","doi-asserted-by":"publisher","first-page":"809","DOI":"10.4244\/EIJ-D-21-00300","volume":"17","author":"G Nickenig","year":"2021","unstructured":"Nickenig, G. et al. Thirty-day outcomes of the cardioband tricuspid system for patients with symptomatic functional tricuspid regurgitation: the TriBAND study. EuroIntervention 17, 809\u2013817 (2021).","journal-title":"EuroIntervention"},{"key":"1233_CR123","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1016\/j.jaccas.2020.08.032","volume":"2","author":"VY Reddy","year":"2020","unstructured":"Reddy, V. Y. et al. First-in-human percutaneous circumferential annuloplasty for secondary tricuspid regurgitation. JACC Case Rep. 2, 2176\u20132182 (2020).","journal-title":"JACC Case Rep."},{"key":"1233_CR124","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT04073979."},{"key":"1233_CR125","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2020.00139","volume":"7","author":"G Muntan\u00e9-Carol","year":"2020","unstructured":"Muntan\u00e9-Carol, G. et al. Transcatheter tricuspid valve intervention: coaptation devices. Front. Cardiovasc. Med. 7, 139 (2020).","journal-title":"Front. Cardiovasc. Med."},{"key":"1233_CR126","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1016\/j.jacc.2024.02.045","volume":"83","author":"RT Hahn","year":"2024","unstructured":"Hahn, R. T. et al. Managing implanted cardiac electronic devices in patients with severe tricuspid regurgitation: JACC state-of-the-art review. J. Am. Coll. Cardiol. 83, 2002\u20132014 (2024).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1233_CR127","doi-asserted-by":"publisher","DOI":"10.1093\/ejcts\/ezac239","volume":"62","author":"D Carino","year":"2022","unstructured":"Carino, D. et al. Surgical treatment of tricuspid valve regurgitation in patients with cardiac implantable electronic devices: long-term results. Eur. J. Cardiothorac. Surg. 62, ezac239 (2022).","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"1233_CR128","doi-asserted-by":"publisher","DOI":"10.1016\/j.shj.2024.100335","volume":"8","author":"D Furman","year":"2024","unstructured":"Furman, D. et al. Transcatheter tricuspid valve clinical trials: incomplete data and FDA-approved devices. Struct. Heart 8, 100335 (2024).","journal-title":"Struct. Heart"},{"key":"1233_CR129","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1002\/ejhf.3532","volume":"27","author":"M Kassar","year":"2025","unstructured":"Kassar, M. et al. The prognostic value of the Dandel\u2019s index in patients undergoing tricuspid transcatheter edge-to-edge repair. Eur. J. Heart Fail. 27, 1511\u20131522 (2025).","journal-title":"Eur. J. Heart Fail."},{"key":"1233_CR130","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1002\/ejhf.2307","volume":"23","author":"M Unterhuber","year":"2021","unstructured":"Unterhuber, M. et al. Cardiac output states in patients with severe functional tricuspid regurgitation: impact on treatment success and prognosis. Eur. J. Heart Fail. 23, 1784\u20131794 (2021).","journal-title":"Eur. J. Heart Fail."},{"key":"1233_CR131","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.jcin.2024.10.023","volume":"18","author":"L Stolz","year":"2025","unstructured":"Stolz, L. et al. Impact of pulmonary hypertension on outcomes after transcatheter tricuspid valve edge-to-edge repair. JACC Cardiovasc. Interv. 18, 325\u2013336 (2025).","journal-title":"JACC Cardiovasc. Interv."},{"key":"1233_CR132","unstructured":"PCR Tricuspid Focus Group. Echocardiographic guide on tricuspid valve interventions. PCR Online https:\/\/www.pcronline.com\/Network\/Tricuspid-Focus-Group\/Publications\/Echocardiographic-guide-on-tricuspid-valve-interventions (2025)."}],"container-title":["Nature Reviews Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41569-025-01233-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41569-025-01233-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41569-025-01233-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T12:03:25Z","timestamp":1779278605000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41569-025-01233-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,2]]},"references-count":132,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["1233"],"URL":"https:\/\/doi.org\/10.1038\/s41569-025-01233-z","relation":{},"ISSN":["1759-5002","1759-5010"],"issn-type":[{"value":"1759-5002","type":"print"},{"value":"1759-5010","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,2]]},"assertion":[{"value":"4 November 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"K.P.R. has received speaker fees from Boehringer Ingelheim, Edwards Lifesciences and ReCor Medical, and has received consultant fees from Gradient Denervation Technologies. A.C. is a proctor for Abbott Vascular and has received speaker fees from Abbott Vascular, Bristol Myers Squibb, Edwards Lifesciences, GE Healthcare, MSD and Pfizer. R.E.-L. is a consultant for Abbott Vascular, Boston Scientific, Edwards Lifesciences, Jenscare, Valgen and Venus Medtech. V.D. has received speaker fees from Abbott Structural, Edwards Lifesciences, GE Healthcare, JenaValve, Medtronic, Novartis, Philips, P&F Products & Features and Siemens. M.S. is a consultant and speaker for Abbott Vascular, Edwards Lifesciences, GE Healthcare, Medtronic and Siemens Healthineers. F.P. has received travel funds from Abbott Vascular, Edwards Lifesciences, InQB8 Medical Technologies, Medira and Siemens Healthineers, and an institutional research grant from Abbott Vascular. N.F. is a consultant for Abbott, Edwards Lifesciences, InQB8 Medical Technologies, Medtronic, TRiCares and Venus MedTech. A.L. is a consultant for or advisory board member of Abbott, Boston Scientific, Edwards Lifesciences, Medtronic and V-dyne. N.P. is a proctor and consultant for Abbott, Highlife, Medtronic and Peijia, and is the cofounder of Tomoverse. P.L. has received institutional fees and research grants from Abbott Vascular, Edwards Lifesciences and ReCor, honoraria from Abbott Medical, Boehringer Ingelheim, Daiichi Sankyo, Edwards Lifesciences, Innoventric, Medtronic and ReCor, and has stock options with Innoventric. T.M. is a consultant for 4C, Abbott, Anteris Technologies, Edwards Lifesciences and Medtronic, and is a shareholder of Versa. J.H. is a speaker for and has received research support from Edwards Lifesciences. R.T.H. has received speaker fees from Abbott Structural, Baylis Medical, Edwards Lifesciences and Philips Healthcare, and has institutional consulting contracts for which she receives no direct compensation with Abbott Structural, Boston Scientific, Edwards Lifesciences, Medtronic and Novartis. M.B.L. has received institutional clinical research support from Abbott, Boston Scientific, Edwards Lifesciences and Medtronic. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}